1. Home
  2. BCG vs CCEL Comparison

BCG vs CCEL Comparison

Compare BCG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCG

Binah Capital Group Inc.

HOLD

Current Price

$2.68

Market Cap

44.7M

Sector

N/A

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.54

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCG
CCEL
Founded
2016
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7M
32.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
BCG
CCEL
Price
$2.68
$3.54
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
42.0K
6.7K
Earning Date
11-13-2025
10-15-2025
Dividend Yield
N/A
11.20%
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$178,203,000.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
$72.27
N/A
Revenue Growth
10.19
N/A
52 Week Low
$1.36
$3.19
52 Week High
$5.81
$8.79

Technical Indicators

Market Signals
Indicator
BCG
CCEL
Relative Strength Index (RSI) 57.95 43.37
Support Level $2.17 $3.19
Resistance Level $3.25 $3.80
Average True Range (ATR) 0.30 0.25
MACD 0.03 0.00
Stochastic Oscillator 56.23 48.90

Price Performance

Historical Comparison
BCG
CCEL

About BCG Binah Capital Group Inc.

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: